For example, despite its immunogenic potential of wilms’ tumor protein 1 (WT1) in mice and clinical trials [11], our data indicated that a WT1-based vaccine was not able to induce potent CD8+ T cells to either prevent or cure WT1-expressing mesothelioma [5]. The gene discussed is CD8A; the disease is mesothelioma.